Cargando…
Immunoregulatory Sertoli Cell Allografts Engineered to Express Human Insulin Survive Humoral-Mediated Rejection
An effective treatment and possible cure for type 1 diabetes is transplantation of pancreatic islets. Unfortunately, transplanted islets are rejected by the immune system with humoral-mediated responses being an important part of rejection. Sertoli cells (SC), an immune regulatory cell shown to surv...
Autores principales: | Washburn, Rachel L., Hibler, Taylor, Kaur, Gurvinder, Sabu-Kurian, Anna, Landefeld, Alissa, Dufour, Jannette M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9780793/ https://www.ncbi.nlm.nih.gov/pubmed/36555540 http://dx.doi.org/10.3390/ijms232415894 |
Ejemplares similares
-
Sertoli Cell Immune Regulation: A Double-Edged Sword
por: Washburn, Rachel L., et al.
Publicado: (2022) -
Mouse Sertoli Cells Inhibit Humoral-Based Immunity
por: Washburn, Rachel L., et al.
Publicado: (2022) -
Sertoli Cells Engineered to Express Insulin to Lower Blood Glucose in Diabetic Mice
por: Kaur, Gurvinder, et al.
Publicado: (2018) -
An overview of a Sertoli cell transplantation model to study testis morphogenesis and the role of the Sertoli cells in immune privilege
por: Kaur, Gurvinder, et al.
Publicado: (2017) -
Genetically engineered immune privileged Sertoli cells: A new road to cell based gene therapy
por: Kaur, Gurvinder, et al.
Publicado: (2012)